These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33980771)

  • 1. Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Iijima T; Jojima T; Hosonuma S; Ohhira E; Tomaru T; Kogai T; Usui I; Aso Y
    Endocr J; 2021 Oct; 68(10):1187-1195. PubMed ID: 33980771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with methimazole on circulating CD4
    Hirao N; Iijima T; Tanuma D; Ohira E; Kurai H; Shinzawa T; Kase M; Sakurai S; Tomaru T; Jojima T; Usui I; Aso Y
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):841-848. PubMed ID: 35692119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
    Bossowski A; Urban M; Stasiak-Barmuta A
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
    Gessl A; Waldhäusl W
    Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
    Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
    Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
    Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium maelstrom: recalcitrant hypocalcaemia following rapid correction of thyrotoxicosis, exacerbated by pregnancy.
    Shin T; Guerrero AF
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25969482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
    Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
    Mori Y; Hiromura M; Terasaki M; Kushima H; Ohara M; Fukui T; Takahashi Y; Yamagishi SI
    J Int Med Res; 2021 Mar; 49(3):300060521996192. PubMed ID: 33682498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
    Kretowski A; Myśliwiec J; Kinalska I
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treatment with methimazole on the Bcl-2 expression in CD8+ peripheral blood lymphocytes in children with Graves' disease.
    Klatka M; Grywalska E; Polak A; Roliński J
    Ann Agric Environ Med; 2013; 20(4):884-8. PubMed ID: 24364474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease.
    Iwona BS; Jadwiga SS; Elzbieta K; Leszek S
    World J Pediatr; 2008 Nov; 4(4):274-82. PubMed ID: 19104891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis.
    Iwatani Y; Amino N; Hidaka Y; Kaneda T; Ichihara K; Tamaki H; Matsuzuka F; Fukata S; Kuma K; Miyai K
    Clin Exp Immunol; 1992 Mar; 87(3):444-9. PubMed ID: 1347493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.
    Brown JJ; Datta V; Browning MJ; Swift PG
    J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1575-9. PubMed ID: 15570997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.